NR505 wk2 Discussion Part Three (graded)
Please provide a summary of the case or information you have
discussed this week.
Topic responses
Discussion
Collapse All
More
Sort By:
Rogelio Enabe
3/7/2017 1:27:08 AM
Wk2_discussion3
Dr. Taylor and class,
This week’s discussions have been interesting and showed us the
complexity of data gathering as what disease should we prevent
and prioritize basing on the risk factors presented to us. I initially,
presented my case to submit Shelly to pap and HPV tests
,because I believe that this step is the right one in preventing
cervical cancer to which she is at risk.
On part two of the discussion, I realized that smoking predisposes
her to almost every type of cancer along with additional history
among her family members. This prompted me to stress more on
smoking cessation. Compliance is a priority and a good smoking
cessation plan with education and group support will help her
tremendously.
One thing that contributes to the success of a smoking cessation
program is to emphasize to the patient the financial advantage if
they free themselves from smoking. Kahenhe et al, mentioned
that in an effort to encourage the program, as of January 2014,
Affordable Care Act prevents state Medicaid programs from
omitting coverage to any FDA approved cessation medications.
Therefore, the patients could benefit by not buying cigarettes and
having coverage for their cessation medications. We don’t know
what will happen to this law but it would be nice to retain such
benefits.
Reference
Kahende, J., Malarcher, A., England, L., Zhang, L., Mowery, P.,
Xu, X., Sevilimedu, V., & Rolle, I. (February 16, 2017). Utilization
of smoking cessation medication benefits among medicaid fee-
for-service enrollees 1999–2008. PLoS ONE, 12 (2), 1-15.
Show Less
Amber Curry
3/10/2017 7:47:37 AM
,Summary
The case study this week greatly enhanced my knowledge about
screening and prevention of disease. Specifically, I became familiar with
validity, reliability, and the positive predictive value of screening tools.
Validity encompasses two components; these are sensitivity and
specificity. Sensitivity refers the ability for the test to identify who
possesses the disease, while specificity refers the ability to identify
individuals who do not have the disease (Gordis, 2014). I gained the
ability to interpret and apply validity and positive predictive value in a
clinical scenario. Throughout this, I discovered that the higher
percentage indicates a high validity. This specifies that the test can
correctly identify individuals who possess a disease and those who do
not.
In the scenario of cervical cancer screening, it is important for
women with a familial history to obtain a Papanicolaou (Pap) screening.
Many of Shelby’s risk factors including smoking, history of cystoscopy
and family history of “woman cancer” indicate that a pap screening was
necessary for her. A pap screening has diagnostic capabilities and
clinical effectiveness for detecting precancerous lesions and cervical
cancer (Cobucci et al.,2016). I learned that this test does have high
validity and is reliable, but would be more beneficial if combined with
HPV screening.
References
Cobucci, R., Maisonnette, M., Macedo, E., Santos-Filho, F.C.,
Rodovalho, P., Nobrega, M.M. &
Goncalves, A. (2016). Pap test accuracy and severity of squamous
intraepithelial lesion. Indian Journal of Cancer, 53(1), 74-76.
doi: 10.4103/0019-509x.180825
Gordis, L. (2014). Epidemiology (5th ed.). Philadelphia, PA: Elsevier
Saunders.
Show Less
, Melissa Barnesreply to Amber Curry
3/10/2017 3:48:04 PM
RE: Summary
Hi Amber,
While it was evident that Shelby was at risk for both cervical and
pulmonary cancer, I chose to run further testing for the lung cancer. My
thought process was due to her actively consuming a daily pack of
cigarettes for over a decade. While I was not naïve to her risks for
cervical cancer, I took into consideration the she was young and her
results were over three years old. However, with her maternal aunt
having a “woman’s cancer” it changed my route of thinking. I too
learned this week that while a pap smear is valid, combined with the
HPV test, screening becomes more reliable. The Pap test checks the
cervix for abnormal cells that can turn into cervical cancer while the
HPV test checks the cervix for the HPV virus that causes cervical cells.
This cotesting screening can find early problems before they become
cancer (Cervical cancer screening with the HPV test and the Pap test in
women ages 30 and older, 2016). Thanks for sharing your ideas.
Cervical cancer screening with the HPV test and the Pap test in women
ages 30 and older. (2016). Retrieved from http://www.cdc.gov
Show Less
Please provide a summary of the case or information you have
discussed this week.
Topic responses
Discussion
Collapse All
More
Sort By:
Rogelio Enabe
3/7/2017 1:27:08 AM
Wk2_discussion3
Dr. Taylor and class,
This week’s discussions have been interesting and showed us the
complexity of data gathering as what disease should we prevent
and prioritize basing on the risk factors presented to us. I initially,
presented my case to submit Shelly to pap and HPV tests
,because I believe that this step is the right one in preventing
cervical cancer to which she is at risk.
On part two of the discussion, I realized that smoking predisposes
her to almost every type of cancer along with additional history
among her family members. This prompted me to stress more on
smoking cessation. Compliance is a priority and a good smoking
cessation plan with education and group support will help her
tremendously.
One thing that contributes to the success of a smoking cessation
program is to emphasize to the patient the financial advantage if
they free themselves from smoking. Kahenhe et al, mentioned
that in an effort to encourage the program, as of January 2014,
Affordable Care Act prevents state Medicaid programs from
omitting coverage to any FDA approved cessation medications.
Therefore, the patients could benefit by not buying cigarettes and
having coverage for their cessation medications. We don’t know
what will happen to this law but it would be nice to retain such
benefits.
Reference
Kahende, J., Malarcher, A., England, L., Zhang, L., Mowery, P.,
Xu, X., Sevilimedu, V., & Rolle, I. (February 16, 2017). Utilization
of smoking cessation medication benefits among medicaid fee-
for-service enrollees 1999–2008. PLoS ONE, 12 (2), 1-15.
Show Less
Amber Curry
3/10/2017 7:47:37 AM
,Summary
The case study this week greatly enhanced my knowledge about
screening and prevention of disease. Specifically, I became familiar with
validity, reliability, and the positive predictive value of screening tools.
Validity encompasses two components; these are sensitivity and
specificity. Sensitivity refers the ability for the test to identify who
possesses the disease, while specificity refers the ability to identify
individuals who do not have the disease (Gordis, 2014). I gained the
ability to interpret and apply validity and positive predictive value in a
clinical scenario. Throughout this, I discovered that the higher
percentage indicates a high validity. This specifies that the test can
correctly identify individuals who possess a disease and those who do
not.
In the scenario of cervical cancer screening, it is important for
women with a familial history to obtain a Papanicolaou (Pap) screening.
Many of Shelby’s risk factors including smoking, history of cystoscopy
and family history of “woman cancer” indicate that a pap screening was
necessary for her. A pap screening has diagnostic capabilities and
clinical effectiveness for detecting precancerous lesions and cervical
cancer (Cobucci et al.,2016). I learned that this test does have high
validity and is reliable, but would be more beneficial if combined with
HPV screening.
References
Cobucci, R., Maisonnette, M., Macedo, E., Santos-Filho, F.C.,
Rodovalho, P., Nobrega, M.M. &
Goncalves, A. (2016). Pap test accuracy and severity of squamous
intraepithelial lesion. Indian Journal of Cancer, 53(1), 74-76.
doi: 10.4103/0019-509x.180825
Gordis, L. (2014). Epidemiology (5th ed.). Philadelphia, PA: Elsevier
Saunders.
Show Less
, Melissa Barnesreply to Amber Curry
3/10/2017 3:48:04 PM
RE: Summary
Hi Amber,
While it was evident that Shelby was at risk for both cervical and
pulmonary cancer, I chose to run further testing for the lung cancer. My
thought process was due to her actively consuming a daily pack of
cigarettes for over a decade. While I was not naïve to her risks for
cervical cancer, I took into consideration the she was young and her
results were over three years old. However, with her maternal aunt
having a “woman’s cancer” it changed my route of thinking. I too
learned this week that while a pap smear is valid, combined with the
HPV test, screening becomes more reliable. The Pap test checks the
cervix for abnormal cells that can turn into cervical cancer while the
HPV test checks the cervix for the HPV virus that causes cervical cells.
This cotesting screening can find early problems before they become
cancer (Cervical cancer screening with the HPV test and the Pap test in
women ages 30 and older, 2016). Thanks for sharing your ideas.
Cervical cancer screening with the HPV test and the Pap test in women
ages 30 and older. (2016). Retrieved from http://www.cdc.gov
Show Less
